arrow
P

Priya Jayachandran

University of Southern California
H指数:20
被引数:1,680

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Activation of the endocytosis pathway stratifies subtypes and therapeutic sensitivity in colorectal cancer

激活内吞通路对结直肠癌亚型和治疗敏感性的分层作用

2026-10-190
OAAI
Molecular and immune profiling of HER2-low, HER2 ultra-low, and HER2-null male breast cancer

HER2低表达、HER2超低表达和HER2缺失型男性乳腺癌的分子和免疫图谱分析

Breast
IF7.9
2026-08-010
PRE
First-line PD-1+/- CTLA-4 blockade in patients with deficient mismatch repair and/or microsatellite instability-high metastatic colorectal cancer

一线PD-1+/−联合CTLA-4阻断治疗错配修复缺陷和/或微卫星高度不稳定转移性结直肠癌患者

2025-09-011
OA
Prognostic impact of the BRAF V600E mutation in patients with MSI-high metastatic colorectal cancer treated with immune checkpoint inhibitors

MSI-High结直肠癌患者接受免疫检查点抑制剂治疗后BRAF V600E突变对预后的影响

2025-07-120
PRE
Comprehensive characterization of MCL-1 in patients with colorectal cancer: Expression, molecular profiles, and outcomes
2024-12-300
PRE
Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer
2024-07-014
OA
ACE-Breast-03: A phase 2 study of ARX788, a novel next-generation anti-HER antibody-drug conjugate in HER2-positive metastatic breast cancer patients previously treated with trastuzumab deruxtecan
2024-05-020
PRE
Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer
2024-04-011
PRE
A compound targeting the circadian clock protein CRY2 enhances therapeutic efficacy of bevacizumab in a colorectal cancer (CRC) xenograft model
2024-03-221
PRE
Clock Genes in Breast Cancer
2023-03-011
PRE